Skip to main content
. 2025 Oct 23;17(21):3413. doi: 10.3390/cancers17213413
AC Anticoagulation
ADAMTS13 A Disintegrin And Metalloproteinase with Thrombospondin Motifs 13
AFP Alpha-Fetoprotein
ALBI Albumin Bilirubin
Ang-2 Angiopoietin 2
AnxA5/PS Annexin A5/Phosphatidylserine
AtezoBev Atezolizumab–Bevacizumab treatment
AVB Acute Variceal Bleeding
CD61/CD62P Cluster of Differentiation 61/62P
CI Confidence Interval
CPS Child–Pugh Score
CRP C-Reactive Protein
CSC (EpCAM+) Cancer Stem Cells (Epithelial Cell Adhesion Molecule positive)
CSPH Clinically Significant Portal Hypertension
CTP Child Turcotte Pugh
CXCL C-X-C Motif Chemokine
DOAC Direct Oral Anticoagulant
DVT Deep Vein Thrombosis
ECOG PS Eastern Cooperative Oncology Group Performance Status
EPCR Endothelial Protein C Receptor
ET-1 Endothelin 1
EVs/MVs Extracellular Vesicles/Microvesicles
HCC Hepatocellular Carcinoma
HMGB1 High-Mobility Group Box 1
HR Hazard Ratio
ICAM-1 Intercellular Adhesion Molecule 1
IL-6 Interleukin 6
Lenv Lenvatinib
LMWH Low-Molecular-Weight Heparin
lncRNA Long Non-Coding RNA
LPS Laparoscopic Surgery
LRT Locoregional Therapy
MCF Maximum Clot Firmness
MA Maximum Amplitude
miR MicroRNA
MP Microparticles
MVI Macrovascular Invasion
MWA Microwave Ablation
NETosis Neutrophil Extracellular Trap Formation
NO Nitric Oxide
OLT Orthotopic Liver Transplantation
OR Odds Ratio
OS Overall Survival
PAI-1 Plasminogen Activator Inhibitor 1
PAP Plasmin Antiplasmin Complex
PE Pulmonary Embolism
pEV Platelet-derived Extracellular Vesicle
PFS Progression-Free Survival
PGI2 Prostacyclin (Prostaglandin I2)
PLT Platelet Count
p-y Person Years
PVT Portal Vein Thrombosis
ROTEM Rotational Thromboelastometry
ROS Reactive Oxygen Species
SVT Splanchnic Vein Thrombosis
TAFI Thrombin-Activatable Fibrinolysis Inhibitor
TEG-PM Thromboelastography with Platelet Mapping
TF Tissue Factor
TGA Thrombin Generation Assay
TM Thrombomodulin
TMPs Tumor-derived Microparticles
TNF-α Tumor Necrosis Factor alpha
TPO Thrombopoietin
uPA/uPAR Urokinase-type Plasminogen Activator/uPA Receptor
vWF von Willebrand Factor
VKA Vitamin K Antagonist
VEGF/VEGFR Vascular Endothelial Growth Factor/VEGF Receptor
VTE Venous Thromboembolism
YAP Yes-associated Protein